Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke

A newer-generation stroke drug is outperforming the standard clot buster. A neurologist explains how tenecteplase saves both time and money when it comes to treating ischemic stroke.

from Latest Science News -- ScienceDaily https://ift.tt/C3Pn69V

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence